In the future, the effect can be enhanced by optimizing the delivery system (such as nanocarriers, microneedle technology) or combining treatment regimens
Lower colorectal cancer incidence with GLP-1s Across the study population, there was a 36% reduction in colorectal cancer risk in the GLP-1 group compared with aspirin users
Molska M, Mruczyk K, Cisek-Woniak A, Prokopowicz W, Szydeko P, Jakuszewska Z, et al
Cost per visit is the lowest of any IV-clinic service
ABSTRACT KEY FIGURE Highlights The DEVELOPMENT AND USE OF GLUCAGON-LIKE PEPTIDE-1 STRUCTURE, DISTRIBUTION, AND PHYSIOLOGICAL FUNCTION OF GLP-1 GLP-1 MODULATES LIPID METABOLISM CLINICAL APPLICATION OF GLP-1 IN LIPID METABOLISM AND ADIPOSE-RELATED DISORDERS GLP-1 AND DUAL AGONISTS CONCLUSIONS NOTES REFERENCES About this article ABSTRACT Glucagon-like peptide-1 (GLP-1) is a 30-amino acid peptide hormone that is mainly expressed in the intestine and hypothalamus